Iridian Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Iridian Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-14,484	Closed	-$135K	–	89
2014 Q4	$135K	Sell	14,484 -6,620	-31%	-$63.8K	﹤0.01%	72
2014 Q3	$211K	Buy	21,104 +440	+2%	+$4.48K	﹤0.01%	82
2014 Q2	$213K	Sell	20,664 -8,510	-29%	-$92K	﹤0.01%	92
2014 Q1	$363K	Sell	29,174 -13,870	-32%	-$164K	﹤0.01%	69
2013 Q4	$529K	Sell	43,044 -7,900	-16%	-$82.1K	0.01%	58
2013 Q3	$439K	Buy	50,944 +9,530	+23%	+$82.3K	0.01%	66
2013 Q2	$360K	Buy	+41,414	New	+$370K	﹤0.01%	92

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Iridian Asset Management's ELOS Position: Q1 2015 in Review

Iridian Asset Management sold out of Syneron Medical Ltd (ELOS) in Q1 2015, closing a stake of 14,484 shares — an estimated $135K sold.

Iridian Asset Management first reported a position in ELOS in Q2 2013 and held it in 7 quarters. The position peaked at $529K in Q4 2013. 80 funds tracked by Wall St. Rank hold ELOS as of Q1 2015.

Iridian Asset Management reported no remaining Syneron Medical Ltd position as of Q1 2015 after selling out during the quarter.
Iridian Asset Management sold 14,484 Syneron Medical Ltd shares in Q1 2015, an estimated $135K.
Iridian Asset Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 7 quarters.
Iridian Asset Management's Syneron Medical Ltd position peaked at $529K in Q4 2013.
80 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2015.

Based on Iridian Asset Management's 13F filing for Q1 2015, filed 8 May 2015.